CBDG OTC
THC Farmaceuticals, Inc.
1W: +0.0%
1M: -14.0%
3M: +118.2%
YTD: -36.8%
1Y: +83.2%
3Y: -86.7%
5Y: -93.3%
$0.02
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
-$5K
-180.0% ▼
Operating Income
-$30K
-252.7% ▼
Net Income
-$15K
-103.5% ▼
EPS (Diluted)
$-0.00
-103.4% ▼
EBITDA
-$25K
-105.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $10K | $8K | $2K | $10K | $0 |
| YoY Growth | -16.5% | -25.7% | -70.5% | +347.6% | -100.0% |
| Cost of Revenue | $3K | $0 | $952 | $4K | $5K |
| Gross Profit | $8K | $8K | $1K | $6K | -$5K |
| Gross Margin | 74.2% | 100.0% | 57.4% | 61.9% | — |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $166K | $39K | $19K | $15K | -$25K |
| Operating Expenses | $166K | $39K | $19K | $15K | -$25K |
| Operating Income | -$158K | -$33K | -$18K | -$8K | -$30K |
| Operating Margin | -1551.0% | -431.7% | -797.2% | -84.9% | — |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | -$995K | -$121K | -$17K | $426K | -$30K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$499K | -$60K | -$8K | $427K | -$15K |
| Net Margin | -4891.3% | -798.0% | -376.9% | 4269.1% | — |
| EPS (Diluted) | $-0.03 | $-0.00 | $-0.00 | $0.02 | $-0.00 |
| EBITDA | -$994K | -$120K | -$16K | $430K | -$25K |
| Shares Outstanding | 17M | 17M | 18M | 18M | 18M |